We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Research Backs Mammography Screening at 40

By HospiMedica International staff writers
Posted on 15 Dec 2011
Women in their 40s with no family history of breast cancer are just as prone to develop invasive breast cancer, as are women with a family history of the disease, according to a recent research. More...
These results indicate that women in this age group would benefit from yearly mammography screening.

The study’s findings were presented November 29, 2011, at the annual meeting of the Radiological Society of North America (RSNA), held in Chicago (IL, USA). The breast cancer screening guidelines issued by the US Preventive Services Task Force in November 2009 triggered a debate among physicians, patient advocacy groups, and the media. Much of the controversy focused on the recommendation against routine annual mammography screening for women in their 40s.

“We believe this study demonstrates the importance of mammography screening for women in this age group, which is in opposition to the recommendations issued by the task force,” said Stamatia V. Destounis, MD, radiologist and managing partner of Elizabeth Wende Breast Care, LLC (Rochester, NY, USA).

For the study, Dr. Destounis and colleagues performed a retrospective review to identify the number and type of cancers diagnosed among women between the ages of 40 and 49--with and without a family history of breast cancer--who underwent screening mammography at Elizabeth Wende Breast Care from 2000 to 2010. The researchers then compared the number of cancers, incidence of invasive disease and lymph node metastases between the two groups.

Of the 1,071 patients in the 40-49 age group with breast cancer, 373 were diagnosed as a result of screening. Of that 373, 39% had a family history of breast cancer, and 61% had no family history of breast cancer. In the family history group, 63.2% of the patients had invasive disease, and 36.8% had noninvasive disease. In the no family history group, 64% of the patients had invasive disease, and 36% had noninvasive disease. The respective lymph node metastatic rates were 31% and 29%.

“In the 40-49 age group, we found a significant rate of breast cancer and similar rates of invasive disease in women with and without family history,” Dr. Destounis said. “Additionally, we found the lymph node metastatic rate was similar.”

According to Dr. Destounis, these findings highlight the importance of early detection and annual screening mammography for women between the ages of 40 and 49 whether or not they have a family history of breast cancer.

Related Links:
Elizabeth Wende Breast Care



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Medical-Grade Display
HL2316SHTB
Digital Radiography System (Ceiling Free)
Digix CF Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image Cedit: Shutterstock

New Light-Activated Platform Advances Glioblastoma Surgery and Postoperative Treatment

Glioblastoma, an aggressive primary brain tumor, infiltrates healthy tissue and resists complete surgical removal. Residual microscopic disease and the blood–brain barrier limit the effectiveness of adjuvant... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.